HMGU_Icon_Molecular_Targets

Featured Publication, Molecular Targets and Therapeutics, SAT,

Fine-Tuning Immunity: The Role of Ubiquitination in T cell Activation

A new study reveals how two key molecular players – the linear ubiquitin chain assembly complex (LUBAC) and TRAF6 – work together to fine-tune immune signaling in T cells. Published in Nature Communications, the research from the group of Prof.…

HMGU_Icon_Molecular_Targets

Featured Publication, Molecular Targets and Therapeutics, SAT, VIRO,

Vitamin A: A Key to Stopping Ferroptosis and Boosting Neuronal Development

A better understanding of ferroptosis – an iron-dependent form of cell death – is an essential prerequisite for the treatment of (neuro)degenerative diseases and certain types of cancer. A team of researchers led by Dr. Kamyar Hadian from the…

HMGU_Icon_Molecular_Targets

Featured Publication, SAT,

Unraveling Ferroptosis: Tracing Back Cell Death in Human Pathology

A team of Helmholtz Munich scientists has made a significant advancement in the understanding of ferroptosis, a complex form of cell death, by successfully detecting it retrospectively in human pathological conditions. This pioneering research,…

HMGU_Icon_Molecular_Targets

Featured Publication, Molecular Targets and Therapeutics, SAT,

Epstein-Barr Virus: Molecular Mechanism of Lymphoma Development Elucidated

Epstein-Barr Virus (EBV) is widespread and very contagious: according to the World Health Association more than 90 percent of the global population are infected with this virus throughout their lives. The virus causes B and T cell lymphomas (cancer…

HMGU_Icon_Molecular_Targets

Featured Publication, Molecular Targets and Therapeutics, SAT,

A New Guardian of Ferroptosis: Farnesoid X Receptor

Understanding ferroptosis is essential for addressing degenerative diseases and certain cancers. Researchers, led by Dr. Kamyar Hadian from Helmholtz Munich, revealed that the Farnesoid X Receptor (FXR), activated by bile acids, serves as a master…

Dr. Kamyar Hadian and Prof. Dr. Ulrike Protzer

Awards & Grants, Molecular Targets and Therapeutics, SAT, VIRO,

Double Triumph for Helmholtz Munich: Two Researchers Honored with m4 Award from BioM

Prof. Ulrike Protzer and Dr. Kamyar Hadian and their teams from Helmholtz Munich received the prestigious Bavarian m4 Award, a recognition of their exceptional contributions to the advancement of future medicine and two different groundbreaking…